| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $6.9B | $7.1B | $7.7B | $10.2B | $10.2B | $7.5B | $1.5B | $1.6B |
| Cost of Revenue | $5.9B | $5.8B | $6.0B | $6.6B | $6.1B | $5.4B | $5.4B | $5.6B |
| Gross Profit | $1.0B | $1.3B | $1.7B | $3.6B | $4.1B | $2.1B | $1.1B | $1.9B |
| R&D Expense | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $0.7B | $0.7B | $1.2B | $3.1B | $3.6B | $1.7B | $0.1B | $0.2B |
| Net Income | $0.3B | $0.4B | $0.8B | $1.9B | $2.6B | $0.8B | $-0.0B | $-0.1B |
| EPS (Basic) | $0.45 | $0.54 | $1.15 | $2.53 | $3.48 | — | $-0.02 | $-0.12 |
| EPS (Diluted) | $0.45 | $0.54 | $1.15 | $2.53 | $3.47 | — | — | $0.99 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $16.6B | $16.5B | $17.0B | $17.3B | $17.7B | $16.3B | $16.4B | $17.2B |
| Current Assets | $1.7B | $1.7B | $2.3B | $2.7B | $3.1B | $1.6B | $1.6B | $1.6B |
| Cash & Equivalents | $0.5B | $0.7B | $1.2B | $1.6B | $1.9B | $0.5B | $0.1B | $0.3B |
| Total Liabilities | $7.2B | $6.8B | $6.7B | $6.6B | $6.9B | $7.6B | $8.2B | $8.2B |
| Current Liabilities | $1.3B | $1.0B | $0.8B | $1.7B | $1.0B | $0.9B | $1.0B | $1.9B |
| Stockholders' Equity | $9.4B | $9.7B | $10.2B | $10.7B | $10.8B | $8.7B | — | — |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.6B | $1.0B | $1.4B | $2.8B | $3.2B | $1.5B | $1.0B | $1.1B |
| Investing Cash Flow | $-0.5B | $-0.6B | $-0.5B | $-0.8B | $-0.3B | $0.2B | $0.2B | $-0.4B |
| Capital Expenditures | — | — | — | — | — | — | — | $0.4B |
| Financing Cash Flow | $-0.3B | $-0.9B | $-1.3B | $-2.5B | $-1.3B | $-1.4B | $-1.3B | $-1.2B |